|
Market Closed -
Nasdaq
16:00:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 120.77 USD | -0.25% |
|
+0.81% | +22.27% |
| 08-07 | Incyte Insider Sold Shares Worth $273,646, According to a Recent SEC Filing | MT |
| 08-07 | Incyte Insider Sold Shares Worth $1,305,422, According to a Recent SEC Filing | MT |
Company Valuation: Incyte Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,213 | 17,869 | 14,072 | 13,306 | 19,391 | 24,480 | - | - |
| Change | - | 10.21% | -21.25% | -5.44% | 45.73% | 26.24% | - | - |
| Enterprise Value (EV) 1 | 13,865 | 14,630 | 10,416 | 11,148 | 16,293 | 20,231 | 18,668 | 16,854 |
| Change | - | 5.52% | -28.81% | 7.03% | 46.15% | 24.17% | -7.73% | -9.72% |
| P/E | 17.2x | 52.8x | 23.7x | 460x | 15.4x | 53.2x | 16.9x | 15.4x |
| PBR | 4.32x | 4.09x | 2.71x | 3.88x | 3.79x | 4.13x | 3.11x | 2.45x |
| PEG | - | -0.8x | 0.3x | -4.9x | 0x | -0.8x | 0x | 1.6x |
| Capitalization / Revenue | 5.43x | 5.26x | 3.81x | 3.14x | 3.77x | 4.12x | 3.91x | 3.74x |
| EV / Revenue | 4.64x | 4.31x | 2.82x | 2.63x | 3.17x | 3.4x | 2.99x | 2.57x |
| EV / EBITDA | 21.5x | 24.5x | 14.8x | 22.2x | 9.53x | 26.4x | 8.78x | 8.44x |
| EV / EBIT | 23.7x | 25.2x | 16.8x | 26.9x | 10.1x | 23.5x | 8.25x | 6.68x |
| EV / FCF | 24.4x | 16.4x | 22.4x | 44.8x | - | 25.7x | 11.5x | 9.9x |
| FCF Yield | 4.1% | 6.1% | 4.45% | 2.23% | - | 3.89% | 8.72% | 10.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.27 | 1.52 | 2.65 | 0.15 | 6.41 | 2.27 | 7.156 | 7.845 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,986 | 3,395 | 3,696 | 4,241 | 5,141 | 5,943 | 6,253 | 6,550 |
| EBITDA 1 | 643.6 | 597.7 | 703.2 | 503.1 | 1,709 | 766.9 | 2,126 | 1,996 |
| EBIT 1 | 585.8 | 579.4 | 620.5 | 413.9 | 1,616 | 861.3 | 2,264 | 2,524 |
| Net income 1 | 948.6 | 340.7 | 597.6 | 32.62 | 1,287 | 471.7 | 1,473 | 1,692 |
| Net Debt 1 | -2,348 | -3,239 | -3,656 | -2,158 | -3,098 | -4,249 | -5,812 | -7,626 |
| Reference price 2 | 73.40 | 80.32 | 62.79 | 69.07 | 98.77 | 120.77 | 120.77 | 120.77 |
| Nbr of stocks (in thousands) | 220,891 | 222,475 | 224,109 | 192,650 | 196,323 | 202,698 | - | - |
| Announcement Date | 2/8/22 | 2/7/23 | 2/13/24 | 2/10/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 53.2x | 3.4x | 26.38x | -.--% | 24.48B | |
| 18.85x | 4.31x | 10.14x | 0.49% | 79.68B | |
| 37.72x | 12.9x | 24.55x | -.--% | 50.61B | |
| 22.25x | 4.9x | 14.19x | 0.66% | 48.81B | |
| -52.46x | 3.62x | 10.7x | 2.92% | 46.91B | |
| 37.11x | 3.43x | 13.06x | -.--% | 30.86B | |
| -7.42x | 10.34x | -6.67x | -.--% | 25.42B | |
| 71.17x | 6.84x | 45.7x | -.--% | 21.2B | |
| -30.52x | 17.51x | -46.68x | -.--% | 16.39B | |
| 23.31x | 5.02x | 13.06x | -.--% | 16.18B | |
| Average | 17.32x | 7.23x | 10.44x | 0.41% | 36.05B | |
| Weighted average by Cap. | 15.76x | 6.57x | 12.59x | 0.58% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- INCY Stock
- Valuation Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
